相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis
Sayaka Yamaguchi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis
T. Yamamoto et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33
Geethani Bandara et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis: What Is the Best Timing for Stool Sampling?
Margalida Calafat et al.
INFLAMMATORY BOWEL DISEASES (2015)
Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure
Susan E. Piper et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study
Jiayun Shen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
Gudula J. A. M. Boon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer
Guanglin Cui et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Prediction of Endoscopic Disease Activity in Ulcerative Colitis by Two Different Assays for Fecal Calprotectin
Vendel Kristensen et al.
JOURNAL OF CROHNS & COLITIS (2015)
Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders
Rodolfo Sacco et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Adalimumab Induces Deep Remission in Patients With Crohn's Disease
Jean-Frederic Colombel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2014)
Meta-analysis: Fecal Calprotectin for Assessment of Inflammatory Bowel Disease Activity
Jin-Feng Lin et al.
INFLAMMATORY BOWEL DISEASES (2014)
Fecal Hemoglobin and Calprotectin Are Equally Effective in Identifying Patients with Inflammatory Bowel Disease with Active Endoscopic Inflammation
Erik Mooiweer et al.
INFLAMMATORY BOWEL DISEASES (2014)
New targets for mucosal healing and therapy in inflammatory bowel diseases
M. F. Neurath
MUCOSAL IMMUNOLOGY (2014)
Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs
Abbi R. Saniabadi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease
Delphine Labaere et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2014)
Therapeutic guidelines on ulcerative colitis: A GRADE methodology based effort of GETECCU
Fernando Gomollon et al.
GASTROENTEROLOGIA Y HEPATOLOGIA (2013)
Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
Mamdouh A. K. Sedhom et al.
GUT (2013)
European evidence based consensus for endoscopy in inflammatory bowel disease
Vito Annese et al.
JOURNAL OF CROHNS & COLITIS (2013)
IL-33 attenuates development and perpetuation of chronic intestinal inflammation
Philipp Gross et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
Jean Frederic Colombel et al.
GASTROENTEROLOGY (2011)
Soluble ST2: A new and promising activity marker in ulcerative colitis
David Diaz-Jimenez et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy
Waldiceu A. Verri et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Inflammatory Bowel Disease
Arthur Kaser et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Characterization of the Novel ST2/IL-33 System in Patients with Inflammatory Bowel Disease
Carol J. Beltran et al.
INFLAMMATORY BOWEL DISEASES (2010)
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
Valle Garcia-Sanchez et al.
JOURNAL OF CROHNS & COLITIS (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
Gert Van Assche et al.
JOURNAL OF CROHNS & COLITIS (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Clinical implications of mucosal healing for the management of IBD
Guillaume Pineton de Chambrun et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
Luca Pastorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis
G. T. Ho et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction
Domingo A. Pascual-Figal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
J. Chapuis et al.
MOLECULAR PSYCHIATRY (2009)
Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases
A. Diamanti et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal Calprotectin, Lactoferrin, and Endoscopic Disease Activity in Monitoring Anti-TNF-alpha Therapy for Crohn's Disease
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal calprotectin: assessment of a rapid test
T. A. Vestergaard et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2008)
Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation
Hiroko Hayakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
Geert D'Haens et al.
GASTROENTEROLOGY (2007)
Oratory markers in IBD: Magic, or unneccessary toys?
S Vermeire et al.
GUT (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma
J Tibble et al.
GUT (2001)
分享论文
